Carboplatin and Bevacizumab for Recurrent Ependymoma
Clinical trial NCT01295944 · COMPLETED
Trial details
- NCT number
- NCT01295944
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-27
- Primary completion
- 2020-09-23
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.